Outcomes of retesting BRCA negative patients using multigene panels.

about

Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series.Identification of genetic variants for clinical management of familial colorectal tumors.

P2860

Q46755855-4238024C-DD34-4D97-BB4F-E76DCA86335C Q49844031-0CCF1DB0-32E7-4075-AE0C-82E8B0758FB3

P2860

Outcomes of retesting BRCA negative patients using multigene panels.

Item

http://www.wikidata.org/entity/Q39160490

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Outcomes of retesting BRCA negative patients using multigene panels.

@en

Outcomes of retesting BRCA negative patients using multigene panels.

@nl

type

Item

label

Outcomes of retesting BRCA negative patients using multigene panels.

@en

Outcomes of retesting BRCA negative patients using multigene panels.

@nl

prefLabel

Outcomes of retesting BRCA negative patients using multigene panels.

@en

Outcomes of retesting BRCA negative patients using multigene panels.

@nl

P1476

Outcomes of retesting BRCA negative patients using multigene panels

@en

P2093

Amy Paine

http://www.w3.org/2001/XMLSchema#string

Ashley Reeves

http://www.w3.org/2001/XMLSchema#string

Dana Zakalik

http://www.w3.org/2001/XMLSchema#string

Sarah Campian

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene

The impact of next-generation sequencing technology on genetics

Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study

The next controversy in genetic testing: clinical data as trade secrets?

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment

Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.

Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.

P2888

s10689-016-9956-7

P304

319-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10689-016-9956-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Siddhartha Yadav

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27878467

http://www.w3.org/2001/XMLSchema#string

Outcomes of retesting BRCA negative patients using multigene panels.

about

P2860

P2860

Outcomes of retesting BRCA negative patients using multigene panels.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698